Aardvark Therapeutics, Inc. Common Stock (AARD)
Healthcare
Biotechnology
7.10 $
+7.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Aardvark Therapeutics, Inc. Common Stock (AARD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -19 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.6 | -1.2 | -2.2 | -4.2 | -4.0 | -7.7 | -11 | -9.8 | -19 | -14 | -19 | -62 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | -0.1 | 0.0 | -0.6 | 0.0 | 0.0 | -0.1 | -0.7 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.6 | 1.5 | 1.6 | 2.0 | 5.7 | |
| -0.3 | 0.7 | -0.3 | 1.2 | -0.1 | 0.8 | -2.4 | 4.4 | -1.0 | -0.7 | 0.7 | 3.4 | |
| 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | |
| – | – | 0.0 | -0.1 | 0.0 | -12 | -113 | 9.4 | 29 | 24 | 34 | 97 | |
| 0.0 | 0.0 | 0.0 | 83 | 0.1 | -1.0 | 89 | -0.1 | 2.6 | -2.1 | 0.0 | 0.4 | |
| -1.6 | -1.2 | -2.2 | 79 | -3.9 | -21 | -35 | -0.5 | 13 | 7.8 | 15 | 36 | |
| -1.6 | -1.2 | -2.2 | -4.3 | -4.0 | -7.7 | -11 | -9.9 | -19 | -14 | -19 | -62 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.